Emergent Product Development Seattle
Latest round
- Series B
Last raised
- Jul 2004
Total raised
- $32M
Investors
- 6
About Emergent Product Development Seattle
Founded in 1999 in Seattle, US, Emergent Product Development Seattle, LLC focuses on biopharmaceutical innovations. The company was acquired by Emergent BioSolutions Inc. in August 2010.Emergent Product Development Seattle, LLC specializes in the development of biopharmaceutical products, particularly therapeutic antibodies and glycan-based therapeutics. Their core offerings include next-generation antibodies (NGAs) designed to improve treatment efficacy for cancer, autoimmune diseases, and infectious diseases.53 mn for the same year.Emergent Product Development Seattle, LLC aims to launch new therapeutic products addressing emerging health challenges. The company plans to expand into additional markets in Europe and Asia by 2025.
Who invested in Emergent Product Development Seattle
6 investors across 1 round
See all investors in Emergent Product Development Seattle
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jul 14, 2004
Amount
$32M
Investors
Questions about Emergent Product Development Seattle
Who invested in Emergent Product Development Seattle?
Emergent Product Development Seattle has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Emergent Product Development Seattle raised?
Emergent Product Development Seattle has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Emergent Product Development Seattle last raise money?
Emergent Product Development Seattle's most recent round on record is a Series B, in Jul 2004.
What does Emergent Product Development Seattle do?
Founded in 1999 in Seattle, US, Emergent Product Development Seattle, LLC focuses on biopharmaceutical innovations.
Where is Emergent Product Development Seattle headquartered?
Emergent Product Development Seattle is headquartered in Seattle, US.
Which VCs invest in companies like Emergent Product Development Seattle?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Emergent Product Development Seattle's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Emergent Product Development Seattle? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.